#015
After decades of failed drug trials, two new drugs have emerged in slowing memory loss associated with Alzheimer's disease: Leqembi and Donanemab. In Episode #015 I deep dive into novel Alzheimer's therapies to discuss their effectiveness, safety, and how to find out if you're at risk.
Chapters:
(0:00) Introduction
(2:00) Who's most at risk of Alzheimer's Disease?
(5:52) The Amyloid Hypothesis
(7:14) Leqembi approved by FDA
(9:16) Donanenmab may be next
(12:10) Alzheimer's drugs, brain bleeding, and death
(16:01) How do you know if you have Alzheimer's?
(21:20) Dementia and CTE
(22:49) Do taking smart drugs make us more productive? Is it worth the risk?
(27:00) The Connect - viewers' comments from previous episodes
Show Notes:
Alzheimer’s drug being tested Leqembi or Lecanemab
https://www.abc.net.au/news/2023-07-0...
Donanemab:
https://www.abc.net.au/news/2023-05-0...
Systematic failure of Alzheimer’s drug trials:
https://www.abc.net.au/news/health/20...
Are these drugs safe?
https://www.science.org/content/artic...
Symptoms of Alzheimer’s:
https://www.dementia.org.au/about-dem...
Mini Mental State Examination (MMSE)
https://cgatoolkit.ca/Uploads/Content...
CTE in female athlete:
https://theconversation.com/australia...
Smart drugs make you dumb:
https://theconversation.com/smart-dru...
Thanks for reading BioLab Collective with Jack Wang! Subscribe for free to receive new posts and support my work.
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit biolabcollective.substack.com (https://biolabcollective.substack.com...)
Watch video #015 online without registration, duration hours minute second in high quality. This video was added by user BioLab Collective with Jack Wang 27 February 2024, don't forget to share it with your friends and acquaintances, it has been viewed on our site 278 once and liked it 5 people.